Physician profile
Pranav Patel
NPI 1811067275
$1,413.44
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $472 · 2021: $215 · 2022: $11.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $458.07 | 2019-2021 | |
| Abbvie INC. | $324.69 | 2019-2021 | |
| Novo Nordisk INC | $180.19 | 2019-2021 | |
| Lilly USA, LLC | $128.25 | 2019-2021 | |
| Ibsa Pharma INC. | $105.93 | 2019-2021 | |
| Amgen INC. | $54.37 | 2020-2021 | |
| Pfizer INC. | $51.57 | 2019-2020 | |
| Shire North American Group INC | $22.77 | 2019 | |
| Radius Health, INC. | $22.65 | 2019 | |
| Amarin Pharma, INC. | $15.13 | 2019 | |
| Genentech USA, INC. | $15.09 | 2019 | |
| Bausch & Lomb Americas INC. | $11.79 | 2022 | |
| Glaxosmithkline, LLC. | $11.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.